Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Mol Med. 2006 Dec;12(12):595-602. Epub 2006 Oct 19.

The IGF-1 network in lung carcinoma therapeutics.

Author information

1
Department of Biological Chemistry, Medical School, University of Athens, 11527 Athens, Greece.

Abstract

Elucidation of the molecular events that underlie respiratory epithelium carcinogenesis still remains a largely unresolved issue. Various new therapeutic interventions are in advanced clinical testing or in daily clinical practice based on available preclinical findings. However, the complex molecular interplay that characterizes carcinogenesis requires further investigation to identify the pivotal factors and their interactions that might render the treatment of these malignancies more effective. Insulin-like growth factor-1 (IGF-1) network is a new important signalling cascade in lung carcinogenesis. Here, we integrate updated results that further support the significance of IGF-1 molecular circuitry in respiratory epithelium tumourigenesis, and pose future perspectives regarding its optimal use in the therapeutic field.

PMID:
17055338
DOI:
10.1016/j.molmed.2006.10.003
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center